Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Re: Pharma Gets Fines All The Time
View:
Post by Craigbad on Oct 25, 2016 9:18pm

Re: Pharma Gets Fines All The Time

The thing is Concordias balance sheet is on the brink. They just issued debt to pay debt when the business was tiring on all cylinders. The company is not in a good position to deal with further reduced cashflow from the UK bill, the class action lawsuits hitting the courts shortly or a Cma fine which could be up to 10% of global sales. Any one of these things could push the company over the edge. I wouldn't doubt we see the regulators open an investigation soon either. This will likely end up a delist.
Comment by MrHulot on Oct 25, 2016 9:29pm
On the brink? They just closed a $350 million bond offering. Who are you kidding?
Comment by CounterAttack on Oct 25, 2016 10:35pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities